Literature DB >> 11739908

Psychiatric comorbidity among hepatitis C-positive patients.

S P Yovtcheva1, M A Rifai, J K Moles, B J Van der Linden.   

Abstract

This study assessed the prevalence of psychiatric disorders among hepatitis C patients at a Veterans Affairs Medical Center. Medical records of 306 randomly selected hepatitis C-positive patients were reviewed for past and present DSM-IV-based psychiatric disorders. Each psychiatric diagnosis was independently confirmed with DSM-IV criteria using symptoms recorded in the chart. Only independently confirmed diagnoses were included for analysis. Mood disorders were present in 38% of patients; personality disorders in 30%; PTSD in 19%; other anxiety disorders in 9%; and psychotic disorders in 17%. Although alcohol use disorders were found in 86% of this patient population, intravenous drug use disorders were present in only 28%. Our data indicate that prevalence rates of a variety of psychiatric disorders are higher in veterans with hepatitis C than in the general population. Mood, anxiety, personality, and psychotic disorders were all relatively common in these patients. Psychiatric disorders may influence the course and treatment of hepatitis C infection, and psychiatrists as well as internists should be aware of the substantial psychiatric comorbidity in patients with this infection.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11739908     DOI: 10.1176/appi.psy.42.5.411

Source DB:  PubMed          Journal:  Psychosomatics        ISSN: 0033-3182            Impact factor:   2.386


  26 in total

1.  Trauma, dissociation, and antiretroviral adherence among persons living with HIV/AIDS.

Authors:  Alex S Keuroghlian; Charles S Kamen; Eric Neri; Susanne Lee; Rhianon Liu; Cheryl Gore-Felton
Journal:  J Psychiatr Res       Date:  2011-06-01       Impact factor: 4.791

Review 2.  The epidemiology of substance use disorders in US Veterans: A systematic review and analysis of assessment methods.

Authors:  Chiao-Wen Lan; David A Fiellin; Declan T Barry; Kendall J Bryant; Adam J Gordon; E Jennifer Edelman; Julie R Gaither; Stephen A Maisto; Brandon D L Marshall
Journal:  Am J Addict       Date:  2015-12-22

3.  Interferon-alpha Treatment of Hepatitis C Patients With Psychiatric Illness: Evidence-Based Risk-Benefit Assessment.

Authors:  Muhamad Aly Rifai
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2005

4.  Interferon-alpha treatment of patients with Hepatitis C: the role of a comprehensive risk-benefit assessment.

Authors:  Muhamad Aly Rifai; Jennifer M Loftis; Peter Hauser
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

5.  Psychiatric care of the patient with hepatitis C: a review of the literature.

Authors:  Muhamad Aly Rifai; Ondria C Gleason; Douha Sabouni
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2010

6.  Major depressive disorder in hepatitis C: an open-label trial of escitalopram.

Authors:  Ondria C Gleason; William R Yates; Michelle A Philipsen
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2005

7.  Psychiatric and substance use disorders among methadone maintenance patients with chronic hepatitis C infection: effects on eligibility for hepatitis C treatment.

Authors:  Steven L Batki; Kelly M Canfield; Robert Ploutz-Snyder
Journal:  Am J Addict       Date:  2011-05-31

8.  Hepatitis C treatment of patients with bipolar disorder: a case series.

Authors:  Muhamad Aly Rifai
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2006

Review 9.  Role of the psychiatrist in the care of patients with hepatitis C and HIV/AIDS.

Authors:  Stephen Price; Juanita Goyette
Journal:  Psychiatr Q       Date:  2003

10.  The role of attachment style and depression in patients with hepatitis C.

Authors:  Sanjeev Sockalingam; Diana Blank; Abdulqader Al Jarad; Fahad Alosaimi; Gideon Hirschfield; Susan E Abbey
Journal:  J Clin Psychol Med Settings       Date:  2013-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.